オープン アクセスを義務付けられた論文 - Neeltje Steeghs詳細
一般には非公開: 3 件
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma
A Embaby, SCFA Huijberts, L Wang, R Leite de Oliveira, H Rosing, ...
Clinical Cancer Research 30 (15), 3157-3166, 2024
委任: European Commission
Cancer Core Europe: Leveraging institutional synergies to advance oncology research and care globally
J Carmona, E Chavarria, K Donoghue, C von Gertten, P Oberrauch, ...
Cancer discovery 14 (7), 1147-1153, 2024
委任: European Commission
A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups
MI Mohmaed Ali, AL Nijstad, RJ Boosman, MR Crombag, S Barnett, ...
Clinical Pharmacokinetics 63 (12), 1711-1722, 2024
委任: Cancer Research UK
一般公開: 51 件
Pan-cancer whole-genome analyses of metastatic solid tumours
P Priestley, J Baber, MP Lolkema, N Steeghs, E de Bruijn, C Shale, ...
Nature 575 (7781), 210-216, 2019
委任: Dutch Cancer Society
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and …
J Tabernero, A Grothey, E Van Cutsem, R Yaeger, H Wasan, T Yoshino, ...
Journal of Clinical Oncology 39 (4), 273-284, 2021
委任: US National Institutes of Health
Pervasive chromosomal instability and karyotype order in tumour evolution
TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ...
Nature 587 (7832), 126-132, 2020
委任: US Department of Defense, US National Institutes of Health, Helmholtz …
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
L Angus, M Smid, SM Wilting, J van Riet, A Van Hoeck, L Nguyen, ...
Nature genetics 51 (10), 1450-1458, 2019
委任: Netherlands Organisation for Scientific Research, Cancer Research UK …
The mutational footprints of cancer therapies
O Pich, F Muiños, MP Lolkema, N Steeghs, A Gonzalez-Perez, ...
Nature genetics 51 (12), 1732-1740, 2019
委任: European Commission, Government of Spain
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
W Jiao, G Atwal, P Polak, R Karlic, E Cuppen, A Danyi, J de Ridder, ...
Nature communications 11 (1), 728, 2020
委任: US National Institutes of Health, Netherlands Organisation for Scientific …
The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact
LF van Dessel, J van Riet, M Smits, Y Zhu, P Hamberg, ...
Nature communications 10 (1), 5251, 2019
委任: US National Institutes of Health, Dutch Cancer Society
Tarlatamab, a first-in-class DLL3-targeted bispecific T-cell engager, in recurrent small-cell lung cancer: an open-label, phase I study
L Paz-Ares, S Champiat, WV Lai, H Izumi, R Govindan, M Boyer, ...
Journal of Clinical Oncology 41 (16), 2893-2903, 2023
委任: US National Institutes of Health
Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study
F Meric-Bernstam, RF Sweis, S Kasper, O Hamid, S Bhatia, R Dummer, ...
Clinical Cancer Research 29 (1), 110-121, 2023
委任: US National Institutes of Health
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
EM Stein, DJ DeAngelo, J Chromik, M Chatterjee, S Bauer, CC Lin, ...
Clinical cancer research 28 (5), 870-881, 2022
委任: US National Institutes of Health
Imatinib, sunitinib and pazopanib: from flat‐fixed dosing towards a pharmacokinetically guided personalized dose
K Westerdijk, IME Desar, N Steeghs, WTA van der Graaf, NP van Erp, ...
British journal of clinical pharmacology 86 (2), 258-273, 2020
委任: Dutch Cancer Society
Detection and localization of early-and late-stage cancers using platelet RNA
S GJG, M Arkani, E Post, M Antunes-Ferreira, S D’Ambrosi, DCL Vessies, ...
Cancer Cell 40 (9), 999-1009. e6, 2022
委任: European Commission, Dutch Heart Foundation, Dutch Cancer Society, Narodowe …
A single digital droplet PCR assay to detect multiple KIT exon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumors
PA Boonstra, A Ter Elst, M Tibbesma, LJ Bosman, R Mathijssen, F Atrafi, ...
Oncotarget 9 (17), 13870, 2018
委任: Dutch Cancer Society
Implementation of a multicenter biobanking collaboration for next‐generation sequencing‐based biomarker discovery based on fresh frozen pretreatment tumor tissue biopsies
S Bins, GA Cirkel, CG Gadellaa‐Van Hooijdonk, F Weeber, IJ Numan, ...
The Oncologist 22 (1), 33-40, 2017
委任: Dutch Cancer Society
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial
MC Heinrich, RL Jones, S George, H Gelderblom, P Schöffski, ...
Nature medicine 30 (2), 498-506, 2024
委任: US National Institutes of Health, US Department of Veterans Affairs
Precision dosing of targeted therapies is ready for prime time
SL Groenland, RB Verheijen, M Joerger, RHJ Mathijssen, A Sparreboom, ...
Clinical Cancer Research 27 (24), 6644-6652, 2021
委任: US National Institutes of Health
Location of gastrointestinal stromal tumor (GIST) in the stomach predicts tumor mutation profile and drug sensitivity
AK Sharma, J de la Torre, NS IJzerman, TL Sutton, B Zhao, TM Khan, ...
Clinical Cancer Research 27 (19), 5334-5342, 2021
委任: US National Institutes of Health, US Department of Veterans Affairs
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます